- Waters & Kraus law firm exposes damaging historical
documents from Eli Lilly about Thimerosal (mercury) in vaccines...
- Dear Sir,
- I've received this email and want to share it with everyone
as it could potentially bring down the card house of vaccinations.
- For those of you interested, following is our latest
press release about the documents we obtained from Eli Lilly. When you
read what they knew about mercury, you'll be furious!
- Claire M. Bothwell
- Waters & Kraus, LLP
- 200 Oceangate, Suite 520
- Long Beach, California 90802
- Tel: (562) 436-8833
- Fax: (562) 590-7296
- PRESS RELEASE March 17, 2002 For Immediate Release
- The Dallas-based law firm of Waters & Kraus announced
today that it has received documents as a result of the discovery process
in the case of Counter v. Eli Lilly & Company, et al, currently
pending in Brazoria County, Texas that come from the archives of Eli
Lilly & Company. The documents clearly demonstrate that Lilly's
thimerosal product, the mercury-based vaccine preservative implicated
in a number of recent law suits as causing neurological injury to
infants, was known as early as April 1930 to be dangerous.
- In its apparent eagerness to promote and market
the product, in September, 1930, Eli Lilly secretly sponsored a "human
toxicity" study on patients already known to be dying of meningococcal
meningitis. Senior partner Andrew Waters stated that, "Lilly then
cited this study repeatedly for decades as proof that thimerosal was
of low toxicity and harmless to humans. They never revealed to the scientific
community or the public the highly questionable nature of the original
- While Eli Lilly made every effort to corrupt the
medical and scientific literature, the process of arranging to publish
the results of its questionable secret study, other researchers have
provided Lilly with numerous articles since the 1930's indicating concerns
about thimerosal and its potential hazard to humans who might be exposed
or injected with the substance. The evidence clearly demonstrates that
Eli Lilly was advised repeatedly that their conclusions of low toxicity
were not warranted and that they failed to pass the information on
to appropriate federal and public health authorities. The following
time line illustrates some, but by no means all, of the documentary
evidence on this point from Lilly's internal files:
- 1947 Article received by Lilly: "No eruptions
or reactions have been observed or reported to merthiolate internally,
but it may be dangerous to inject a serum containing merthiolate into a
patient sensitive to merthiolate."
- 1948 Article received by Lilly: "Merthiolate
is such a commonly used preservative for biologicals, plasma, cartilage,
etc., that it would seem important to determine whether harm would
result following its subcutaneous or intravenous injection in skin
- 1950 New York Academy of Science article, "Mercurials
as Antiseptics:" "It (merthiolate) is toxic when injected
parenterally and therefore cannot be used in chemotherapy."
- 1963 Article received by Lilly: "There is
another point of practical significance: does the parenteral injection
of merthiolate-containing fluids cause disturbances in merthiolate-sensitive
patients?" "It is known that persons that are contact sensitive
to a drug may tolerate the same medications internally, but it seems
advisable to use a preservative other than merthiolate for injections in
- 8/17/67 Medical/Science department requests that the
claim "non- toxic" on thimerosal labels be deleted in next printing
- 8/29/67 Draft label changed to "non-irritating
to body tissues," non-toxic omitted.
- 1972 British Medical Journal reports case of skin
burns resulting from the chemical interaction of thimerosal and
- aluminum. "Mercury is known to act as a catalyst
and to cause aluminum to oxidize rapidly, with the production of heat."
"The manufacturers who supply us with thimerosal have been informed."
[Thimerosal is being used in vaccines which also contain aluminum].
- 1972 Article received by Lilly: Merthiolate
in vaccines caused six deaths ? "The symptoms and clinical course
of the six patients suggest subacute mercury poisoning."
- 4/27/76 Lilly responds to Rexall Drug Company's
efforts to place the following warning on Merthiolate product: "Frequent
or prolonged use or application to large areas may cause mercury poisoning."
Lilly objects to this proposed warning, stating:
- "We object to the connection of our trademark
with the unjustified alarm and concern on the part of the user which the
statement is likely to cause? . We are not aware of any instance
of 'mercury poisoning' after decades of marketing this product. This
is because the mercury in the product is organically bound ethylmercury
as a completely non- toxic nature, not methylmercury."
- 1/5/82 FDA's advance notice of proposed rule
making regarding thimerosal:
- "At the cellular level, thimerosal has been found
to be more toxic for human epithelial cells in vitro than mercuric
chloride, mercuric nitrate, and merbromim (mercurichrom)." "It
was found to be 35.3 times more toxic for embryonic chick heart tissue
than for staphylococcus areus." 1950 study showed that thimerosal
was no better than water in protecting mice from potential fatal streptococcal
- "The Panel concludes that thimerosal is not
safe for OTC topical use because of its potential for cell damage if applied
to broken skin and its allergy potential. It is not effective as a
topical antimicrobial because its bacteriastatic action can be reversed."
- 4/7/83 Additional language added to some Lilly
labels: "As with any drug, if you are pregnant or nursing a baby,
seek the advice of a health professional before using this product."
- 1991 Lilly ceases manufacture/sale of thimerosal.
Licensing agreements demonstrate continued profits from the product until
at least 2010.
- 12/8/99 Lilly MSDS regarding thimerosal:
- "Primary Physical & Reproduction Effects:
Nervous System and Reproduction Effects"
- "Effects of exposure include fetal changes.
- "Mercury poisoning may occur."
- "Exposure in children may cause mild to severe
mental retardation... ."
- "Hypersensitivity to mercury is a medical
condition aggravated by exposure."
- CERCLA Hazardous substance ? toxic waste disposal.
- Waters & Kraus is litigating a growing number of
individual cases across the country involving infants that sustained serious
neurological injuries from the thimerosal contained in their pediatric
vaccines. Waters & Kraus is leading the following coalition of firms
in bringing these cases to trial:
- Evert & Weathersby, L.L.C. 3405 Piedmont Road, Suite
225 Atlanta, Georgia 30305-1764 Tel: 404.233.8718
- DORAN & MURPHY, LLP 1234 Delaware Avenue Buffalo,
New York 14209 Tel: 716.884.2000
- Dogan & Wilkinson 726 Delmas Avenue Pascagoula, Mississippi
39567 Tel: 228.762.2272
- O'CONNELL & O'SULLIVAN 217 N. McLean Blvd., Suite
2C Elgin, Illinois 60123 Tel: 847-741-4603
- Hendrickson & Long 214 Capital Street P.O. Box 11070
Charleston, W. VA 25339 Tel: 304.346.5500
- ANDERSON & KRIGER, APLC 40925 County Center Drive,
Suite 210 Temecula, California 92591 Tel: 909.296.5090
- WISE & JULIAN, PC 3555 College Avenue Alton, Illinois
62002 Tel: 618.462.2600
- MARTZELL & BICKFORD 338 Lafayette Street New Orleans,
Louisiana 70130 Tel: 504.581.9065
- NANCE, CACCIATORE AND HAMILTON 525 North Harbor Blvd.
Melbourne, Florida 32935 Tel: 321.254.8416
- FERRARO & ASSOCIATES, P.A. First Union Financial
Center 200 South Biscayne Boulevard, Suite 3800 Miami, Florida 33131 Tel:
- Cantor, Arkema and Edmonds, P.C. First National Bank
Building 823 East Main Street P.O. Box 561 Richmond, VA 23218-0561 Tel:
- Thomasson, Gilbert, Cook & Maguire, LC 715 North
Clark P.O. Box 1180 Cape Girardeau, Missouri 63702-1180 Tel: 573.335.6651
- WALLACE & GRAHAM 525 N. Main Street Salisbury, North
Carolina 28144 Tel: 704-633-5244
- THE HENDLER LAW FIRM, P.C. 816 Congress Avenue, Suite
1100 Austin, Texas 78701 Tel: 512.473.3672